期刊文献+

氨基糖苷类药物诱导大肠埃希菌生物被膜对抗菌药物敏感性变化规律 被引量:1

Antibacterial Agent Sensitivity Changes of E.coli Biofilm Under Induction Pressure of Aminoglycoside Drugs
下载PDF
导出
摘要 采用浓度梯度递增法对3株不同生物被膜形成能力的大肠埃希菌进行4种氨基糖苷类药物(阿米卡星、链霉素、庆大霉素和安普霉素)诱导,考察大肠埃希菌生物被膜对其余8种不同抗菌药物最小抑菌浓度和最小膜清除浓度的变化规律。结果表明,在氨基糖苷类药物诱导压力下,3株不同生物被膜形成能力的菌株对其余8种抗菌药物的最小膜清除浓度比最小抑菌浓度至少增加8倍以上,与诱导前相比,大肠埃希菌形成生物被膜后,其最小膜清除浓度增加的速率比最小抑菌浓度快。 To investigate the changes of minimal inhibitory concentrations (MIC) and minimal biofilm eradiation concentrations (MBEC) of three different biofilm-forming ability E. coli to other eight different antibioctics after the E. coli biofilm formation, the concentration gradient increasing induction method was used for our study under the pressures of four aminoglycoside drugs (amikacin, streptomycin, gentamicin and apramycin). The results showed that under the different concentrations of aminoglycoside drugs, MIC and MBEC of the induced strains increased at least 8 times compared with the pre-induced strains, and the increase rate of MBEC was faster than that of MIC after the E. coli biofilm formation.
出处 《动物医学进展》 CSCD 北大核心 2012年第6期52-55,共4页 Progress In Veterinary Medicine
基金 国家自然科学基金(U0631006) 西南民族大学中央高校基本科研业务费专项基金(11NZYTD02)
关键词 浓度梯度递增法 最小抑菌浓度 最小膜清除浓度 诱导压力 大肠埃希菌 concentration gradient increasing method minimal inhibitory concentration (MIC) minimal biofilm eradiation concentration induction pressure E, coli
  • 相关文献

参考文献7

  • 1Naves P, Delprado G, Hueives L, et al. Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strains[J]. Microb Pathog, 2008, 45:86-91.
  • 2Patel R. Biofilms and antimicrobial resistance[J]. Clin OrthopRelat Res,2005, 437:41-47.
  • 3Cinical and Laboratory Standards Institute. Performance stand- ards for antimierobial susceptibility testing, Twentieth infor- mational supplement [EM/2]. 2010-1-7. http:// www. elsi. org/source/orders/Product _ Display. cfm? section = Shop&task = 3 &CATEGORY = AST&PRODUCT_ TYPE = SALES&SKU= M100S20.
  • 4陈朝喜,朱恒乾,廖晓萍,刘雅红.大肠埃希菌耐药谱型、基因型和生物膜表型关系研究[J].动物医学进展,2011,32(4):59-62. 被引量:7
  • 5Moskowitz S M. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis[J]. J Clin Microbiol,2004, 42 : 1915-1922.
  • 6Fitzpatrick F. The genetics of staphylococcal biofilm forma- tion : will a greater understanding of pathogenesis lead to better management of device-related infection[J]. Clin Microbiol In- fect,2005, 11:967-973.
  • 7Perez-Giraldo C. Moxifloxacin and biofilm production by coagu- lase-negative staphylococci[J]. Chemotherapy, 2004, 50: 101- 104.

二级参考文献15

  • 1余方友,胡龙华,贾坤茹.应用ERIC-PCR对多重耐药大肠埃希菌进行基因分型[J].江西医学检验,2005,23(6):513-514. 被引量:1
  • 2成大荣,黄维嘉,张迎春,张科军,徐建生.不同毒力基因型大肠杆菌的毒力测定[J].动物医学进展,2005,26(12):78-80. 被引量:25
  • 3刘华,祁克宗,涂健,朱良强.鸡源致病性大肠埃希菌菌毛基因研究进展[J].动物医学进展,2006,27(5):16-19. 被引量:4
  • 4Naves P, Delprado G, Hueives L, et al. Correlation between virulence factors and in vitro biofilm formation by Escherichia coil strains[J]. Microb Pathog,2008, 45:86-91.
  • 5Rijavee M, Miiller-Premru M, Zakotnik B, et al. Virulence factors and biofilm production among Encherichia coil strains causing bacteraemia of urinary tract origin[J]. J Med Microbiol, 2008,57(11) :1329-1334.
  • 6Rijavec M, Mtiller-Premru M, Zakotnik B, et al. Virulence lactors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin[J]. J Med Mierobiol, 2008, 57(11):1329-1334.
  • 7National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard MT-A6[S]. National Committee for Clinica Laboratory Standards: Wayne P A ,2003: M7-A6.
  • 8Peeters E, Nelis H J, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates[J]. J Microbiol Methods,2008,72(2) :157-165.
  • 9Stepanovic S, Cirkovie I, Ranin L,et al. Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface [J]. Let in Appl Microbiol, 2004,38 : 428-432.
  • 10Casarez E A, Pillai S D,Di Giouanni G D. Genotype diversity of Escherichia coli isolates in natural waters determined by PFGE and ERIC-PCR[J]. Water Res, 2007,41 : 3643-3648.

共引文献6

同被引文献14

  • 1Meletiadis J,Mouton JW,Meis JF. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical scedosporium prolificans isolates[J].{H}Antimicrobial Agents and Chemotherapy,2003,(1):106-117.
  • 2Heiding P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli[J].{H}Antimicrobial Agents and Chemotherapy,1996,(4):879-885.
  • 3Oram M,Fisher LM. 4-Quindone resistance mutations in the DNA gyrase of Escherichia coli clinical isolate identified by using the polymerase chain reaction[J].{H}Antimicrobial Agents and Chemotherapy,1991,(2):387-389.
  • 4Stratchounski L,Rafalski V. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation:two multicentre studies,UTIAP-1 and UTIAP-2[J].{H}International Journal of Antimicrobial Agents,2006,(Suppl 1):S4-S9.
  • 5Cattior V,Lesprit P,Lascols C. In vivo seletion during ofloxacin therapy of Escherichia coli combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid[J].{H}Journal of Antimicrobial Chemotherapy,2006,(5):1054-1057.
  • 6Petersen A,Christensen JP,Kuhnert P. Vertical transmission of a fuloroquinolone resistant Escherichia coli with in an integrated operation[J].{H}Veterinary Microbiology,2006,(1-3):120-128.
  • 7Karczmarxzyk M,Martins M,Ouinn T. Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing[J].{H}APPLIED AND ENVIRONMENTAL MICROBIOLOGY,2011,(20):7113-7120.
  • 8Morgan-Linnell SK,Boyd LB,Steffen D. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolate[J].{H}Antimicrobial Agents and Chemotherapy,2009,(1):235-242.
  • 9刘华钢,申庆荣,刘丽敏.中药抗菌研究进展[J].时珍国医国药,2010,21(2):463-465. 被引量:62
  • 10陈枫,梁海军,钟利,林雁,唐小平,陈庄,黄永茂.大肠埃希菌对氟喹诺酮类的耐药性及其机制研究[J].中华医院感染学杂志,2012,22(5):884-886. 被引量:10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部